Bendamustine-EAM versus BEAM regimen in patients with mantle cell lymphoma undergoing autologous stem cell transplantation in the frontline setting: a …

T Hueso, T Gastinne, S Garciaz… - Bone marrow …, 2020 - nature.com
The combination of carmustine, etoposide, cytarabine, and melphalan (BEAM) as
conditioning regimen prior to autologous stem-cell transplantation (ASCT) remains the …
被引用次数：21 相关文章

[引用][C] Bendamustine-EAM versus BEAM regimen in patients with mantle cell lymphoma undergoing autologous stem cell transplantation in the frontline setting: a …

T Hueso, T Gastinne, S Garciaz, E Tchernonog… - Bone Marrow …, 2020 - cir.nii.ac.jp
Bendamustine-EAM versus BEAM regimen in patients with mantle cell lymphoma undergoing
autologous stem cell transplantation in the frontline setting: a multicenter retrospective study …

Bendamustine-EAM versus BEAM regimen in patients with mantle cell lymphoma undergoing autologous stem cell transplantation in the frontline setting: a multicenter …

T Hueso, T Gastinne, S Garciaz… - Bone Marrow …, 2020 - go.gale.com
The combination of carmustine, etoposide, cytarabine, and melphalan (BEAM) as
conditioning regimen prior to autologous stem-cell transplantation (ASCT) remains the …

Bendamustine-EAM versus BEAM regimen in patients with mantle cell lymphoma undergoing autologous stem cell transplantation in the frontline setting: a multicenter …

T Hueso, T Gastinne, S Garciaz… - Bone marrow …, 2020 - pubmed.ncbi.nlm.nih.gov
The combination of carmustine, etoposide, cytarabine, and melphalan (BEAM) as
conditioning regimen prior to autologous stem-cell transplantation (ASCT) remains the …

[引用][C] Bendamustine-EAM versus BEAM regimen in patients with mantle cell lymphoma undergoing autologous stem cell transplantation in the frontline setting: a …

T Hueso, T Gastinne, S Garciaz, E Tchernonog… - 2020 - agris.fao.org
Bendamustine-EAM versus BEAM regimen in patients with mantle cell lymphoma
undergoing autologous stem cell transplantation in the frontline setting: a multicenter …

Bendamustine-EAM versus BEAM regimen in patients with mantle cell lymphoma undergoing autologous stem cell transplantation in the frontline setting: a multicenter …

T Hueso, T Gastinne, S Garciaz… - Bone Marrow …, 2020 - hal.science
UNIV-NANTES UNIV-BOURGOGNE UNIV-RENNES1 PRES_CLERMONT CNRS UNIV-
ANGERS EHESS U917 UT1-CAPITOLE COMUE-NORMANDIE UR1-UFR-SVE LNC …

Bendamustine-EAM versus BEAM regimen in patients with mantle cell lymphoma undergoing autologous stem cell transplantation in the frontline setting: a multicenter …

T Hueso, T Gastinne, S Garciaz… - Bone Marrow …, 2020 - europepmc.org
The combination of carmustine, etoposide, cytarabine, and melphalan (BEAM) as
conditioning regimen prior to autologous stem-cell transplantation (ASCT) remains the …

Bendamustine-EAM versus BEAM regimen in patients with mantle cell lymphoma undergoing autologous stem cell transplantation in the frontline setting: a multicenter …

T Hueso, T Gastinne, S Garciaz… - Bone Marrow …, 2020 - univ-rennes.hal.science
UNIV-NANTES UNIV-BOURGOGNE UNIV-RENNES1 PRES_CLERMONT CNRS UNIV-
ANGERS EHESS U917 UT1-CAPITOLE COMUE-NORMANDIE UR1-UFR-SVE LNC …